Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MF6:GR

6.100 EUR 0.016 0.26%

As of 11:36:22 ET on 04/17/2015.

Snapshot for MagForce AG (MF6)

Open: 6.100 Day's Range: 6.100 - 6.430 Volume: 112,286
Previous Close: 6.084 52wk Range: 4.500 - 7.500 1-Yr Rtn: +1.65%

Stock Chart for MF6

No chart data available.
  • MF6:GR 6.165
  • 1D
  • 1M
  • 1Y
6.084
Interactive MF6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MF6

Current P/E Ratio (ttm) 21.7363
Estimated P/E(12/2014) -
Relative P/E vs. DAX 1.1159
Earnings Per Share (EUR) (ttm) 0.2806
Est. EPS (EUR) (12/2014) -0.2070
Est. PEG Ratio -
Market Cap (M EUR) 145.93
Shares Outstanding (M) 23.92
30 Day Average Volume 59,954
Price/Book (mrq) 7.6487
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MF6

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MF6

Magforce AG develops medical technologies. The Company specializes in nanocancer therapy for treatment of cancerous tumors. Magforce's treatment uses nanoparticles containing ironoxide, which are injected into solid tumors in a procedure similar to a biopsy.

Benjamin J Lipps "Ben"Chairman-Mgmt Board/CEOChristian Von VolkmannCFO/Member-Mgmt Board
Hoda TawfikCOO & CMO:Therapy Dev
More Company Profile & Key Executives for MF6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil